MNTA stock: buy or sell

MNTA stock price: $52.48 -0.02% At close on Sep 30th, 2020

Updated on:
Dec 29th, 2020

1

MNTA stock brief

  • After hitting new all-time highs last September, Momenta Pharmaceuticals closed at $52.48 barely moving a -0.02%
  • Last September broke out above its latest top at $52.33

Should I buy Momenta Pharmaceuticals stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $MNTA stock a buy?

Currently, Momenta Pharmaceuticals stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean we expect a selloff for $MNTA in the next few days, or that it may not climb higher. Simply, it doesn't match our recommended trading systems

Should I sell Momenta Pharmaceuticals stock?

When you own stock shares with some profit, it's really difficult to decide the good moment to sell and get your profits. Trading strategies allow us to avoid rash decisions based on our personal feelings or the noise that surrounds the market. Our trading system selects very simple setups to guide us on when is a good moment to sell our shares. Be aware that these setups should not be used for selling short Momenta Pharmaceuticals stock

A guiding principle is that you must never keep an open trade that leads to higher than expected losses at the time of the buy. The moment to sell your stock should always be determined by the stop-loss (automatic or manual)

Is it time to sell Momenta Pharmaceuticals stock?

In the current situation of Momenta Pharmaceuticals there is not any eligible sell setup, so Momenta Pharmaceuticals stock holders with operations in profit can keep their positions

Momenta Pharmaceuticals ratings

In the last month we couldn't find any rating for Momenta Pharmaceuticals

Momenta Pharmaceuticals stock analysis

$MNTA at new Highs

Last September, Momenta Pharmaceuticals marked new all-time highs (ATH) again at $52.53. It's the 4th time in the last 10 sessions, marking an important rally

SMAs overview

MNTA stock SMAs chart

Supports and resistances

Price is at all-time highs and there are not upper resistance levels.

The current supports are:

  • S1: $52.33 (-0.29% below)
  • S2: $39.88 (-24.01% below)
  • S3: $35.13 (-33.06% below)
  • Bollinger bands

    The current distance between the upper and lower bands is less than 5%, indicating that price volatility is at very low levels. Reduced volatility is often the antecedent to a sharp movement (up or down), so we must be alert and manage our buy or sell orders properly

    MNTA stock Bollinger Bands chart

    Relative strength index

    Climbed above the overbought line last September, with a reading of 77.84. The fact that the value is above the level of 70 does not in any way imply a sell point, as stocks can be above 70 for many, many weeks and may continue to rise

    MNTA stock RSI chart

    Momenta Pharmaceuticals stock price history

    Momenta Pharmaceuticals went public priced at an adjusted price1 of $6.75 on Jun 2004. Since then, MNTA stock surged by 677.48%, with an average of 42.34% per year. An investment of $1,000USD on Jun 2004 would have a value of $7,774.81 today.

    1: Adjusted price after possible price splits or reverse-splits

    MNTA stock price history chart

    Price target for Momenta Pharmaceuticals stock

    How much a stock will be priced tomorrow or next week is quite unpredictable. However, many stock price forecasts are published every day by banks, financial institutions and independent analysts.

    The following table shows the price target released by analysts in the last 30 days. If you are a small investor you don't have to trade based on these price targets.

    We don't have any target price posted in the previous 4 weeks for Momenta Pharmaceuticals.

    Earnings and financials

    Momenta Pharmaceuticals ($MNTA) had the investors event and presented the report last October.

    Compared to the same quarter last year, EPS was $-0.45, so reported EPS means 100.00%.

    MNTA ($MNTA) is hosting the Q4 earnings call next February.

    Momenta Pharmaceuticals performance

    MNTA performance compared
    Company1m3m6m
    Momenta Pharmaceuticals ($MNTA) 0.60% 61.10% 118.70%

    Please read:
    The viewpoints contained in this article are personal and not recommendations for you to buy or sell shares. The author of this article does not have an understanding of the individual positions of the reader, his or her own finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Thoughts are expressed for learning reasons only

    MNTA summary

    Wednesday, September 30th, 2020
    Open$52.47
    Close$52.48
    Day range$52.46 - $52.53
    Previous close$52.49
    Session gain-0.02%
    Average true range$0.17
    50d mov avg$43.33
    100d mov avg$38.34
    200d mov avg$32.88
    Earnings dateFebruary 24th, 2021

    Frequently asked questions

    What is Momenta Pharmaceuticals stock symbol?

    Momenta Pharmaceuticals, Inc. is a public company trading in the US stock market with the MNTA symbol

    Is Momenta Pharmaceuticals stock a buy or sell?

    Momenta Pharmaceuticals had no ratings in the last four weeks Read the article to get additional tips on trading MNTA stock.

    Will MNTA go up?

    There were no predictions posted by analysts in the last 4 weeks for Momenta Pharmaceuticals.